| 4814 |
Centers for Disease Control and Prevention |
Html |
en |
Chronic Diseases and Mortality in Canadian Aboriginal Peoples: Learning From the Knowledge |
null |
| non-Aboriginal population | 0.419582 |
| Canada’s Aboriginal | 0.762834 |
| health equity | 0.549389 |
| Nations community | 0.499516 |
| health inequities | 0.436364 |
| health information | 0.433363 |
| unique social determinants | 0.520937 |
| social determinants | 0.622416 |
| M. Indigenous health | 0.504983 |
| urban Aboriginal adults | 0.612643 |
| health gap | 0.508954 |
| total urban cohort | 0.48825 |
| societal risk factors | 0.4685 |
| Manitoba First Nations | 0.491722 |
| urban Aboriginal cohort | 0.616637 |
| arthritis consult health | 0.5374 |
| risk factors | 0.541099 |
| mortality registry data | 0.487011 |
| urban non-Aboriginal Canadians | 0.513211 |
| on-reserve First Nations | 0.488985 |
| community engagement | 0.541663 |
| life expectancy | 0.661914 |
| health status | 0.586403 |
| Aboriginal women | 0.528306 |
|
| Aboriginal Peoples Survey | 0.643919 |
| chronic disease | 0.588195 |
| low plasma apolipoprotein | 0.47837 |
| non-Aboriginal mainstream | 0.416097 |
| main strategic directions.10 | 0.459909 |
| Self-reported arthritis | 0.415559 |
| joint publication initiative | 0.496084 |
| health knowledge | 0.433554 |
| national Aboriginal population | 0.615644 |
| Aboriginal Canadians | 0.517256 |
| conventional social determinants | 0.480445 |
| national community engagement | 0.486163 |
| aboriginal peoples | 0.968314 |
| urban centers | 0.500286 |
| Longitudinal Health Survey | 0.533257 |
| local community engagement | 0.479281 |
| chronic diseases | 0.579882 |
| lower life expectancy | 0.525356 |
| health | 0.650369 |
| high cardiovascular risk | 0.483866 |
| Aboriginal populations | 0.607455 |
| common medical condition | 0.479604 |
| health center | 0.434475 |
| national survey data | 0.475251 |
|
CLICK HERE |
| 6983 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Sierra Leone |
CDC began working in Sierra Leone in 2008 and supports laboratory and surveillance capacity building activities for HIV and other infectious diseases. |
| CDC Foundation | 0.537277 |
| U.S. CDC | 0.934353 |
| 2014-2015 Ebola response | 0.468765 |
| 5-year immunization plan | 0.390789 |
| infectious disease threats | 0.373142 |
| AIDS Relief | 0.383123 |
| antimicrobial resistance | 0.376909 |
| Emergency Operations Centers | 0.371439 |
| national public health | 0.55138 |
| extensive global health | 0.428695 |
| permanent CDC Country | 0.660504 |
| Emergency Plan | 0.390637 |
| standard operating procedures | 0.358404 |
| World Health Organization | 0.422964 |
| vaccine coverage data | 0.367658 |
| MoHS immunization activities | 0.438689 |
| emergency management | 0.37982 |
| public health emergencies | 0.414296 |
| national oral polio | 0.366406 |
| 5-year national laboratory | 0.395251 |
| Emergency Operations | 0.374957 |
| laboratory systems | 0.379283 |
| public health management | 0.445759 |
| Health Security Agenda | 0.562091 |
|
| public health information | 0.416784 |
| GHSA action packages | 0.36874 |
| largest outbreak response | 0.430187 |
| Global Health Security | 0.73615 |
| Epidemiology Training Program | 0.371533 |
| Sierra Leone | 0.814147 |
| U.S. President | 0.403089 |
| biometrics-based immunization tracking | 0.384314 |
| nationwide measles vaccine | 0.369103 |
| Infant mortality rate | 0.391838 |
| new laboratory tests | 0.374518 |
| highest number | 0.38021 |
| public health | 0.682214 |
| Health Security efforts | 0.431873 |
| World Health Statistics | 0.432591 |
| infection prevention | 0.369913 |
| Central Public Health | 0.421044 |
| flaccid paralysis review | 0.367846 |
| MoHS disease surveillance | 0.445655 |
| public health Emergency | 0.442879 |
| Relief building laboratory | 0.410229 |
| West Africa | 0.38017 |
| public health data | 0.417111 |
| CDC technical assistance | 0.613478 |
|
CLICK HERE |
| 7551 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Histoplasmosis Outbreak Among Day Camp Attendees - Nebraska, June 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| logistic regression model | 0.72839 |
| respiratory illness outbreaks | 0.795626 |
| respiratory illness cluster | 0.806283 |
| County Health Department | 0.780458 |
| Douglas County | 0.747162 |
| original MMWR paper | 0.731792 |
| U.S. Government Printing | 0.729282 |
| endemic areas | 0.748107 |
| Human Services | 0.803307 |
| common fungal infection | 0.746769 |
| test p-value | 0.745024 |
| MMWR HTML versions | 0.732749 |
| U.S. Department | 0.719179 |
| Douglas County Dept | 0.717716 |
| camp administrators | 0.699555 |
| dirt floors | 0.734013 |
| wilderness skill training | 0.726182 |
| Laboratory-confirmed histoplasmosis | 0.732033 |
| Bryan F. Buss | 0.722233 |
| picnic tables | 0.976993 |
| electronic PDF version | 0.728302 |
| Histoplasma capsulatum antigen | 0.766038 |
| recreation division | 0.733171 |
| Zoonotic Infectious Diseases | 0.721946 |
|
| histoplasmosis | 0.746493 |
| Benjamin J. Park | 0.725592 |
| campsites | 0.810189 |
| personal protective equipment | 0.732735 |
| Career Epidemiology Field | 0.723355 |
| potentially contaminated areas | 0.735795 |
| additional symptom | 0.738612 |
| probable infection source | 0.730191 |
| camp arrival | 0.704023 |
| separate Internet-based questionnaire | 0.734579 |
| camp counselor | 0.770558 |
| campsite assignments | 0.816981 |
| Public Health Preparedness | 0.736631 |
| bat droppings | 0.758994 |
| camp attendees | 0.753485 |
| case definition | 0.740323 |
| Cochran-Armitage test p-value | 0.735006 |
| referent group | 0.729925 |
| original paper copy | 0.72183 |
| exact test p-value | 0.739478 |
| camp activities | 0.82193 |
| bat guano | 0.892122 |
| Kristin Yeoman | 0.74041 |
|
CLICK HERE |
| 7939 |
Centers for Disease Control and Prevention |
Html |
en |
Guide to Promoting Cancer Prevention in Your Community |
CDC developed this tool kit to help community groups lead cancer prevention efforts. |
| public health expert | 0.604594 |
| Promoting Cancer Prevention | 0.633966 |
| local leaders | 0.390139 |
| cancer prevention | 0.911159 |
| community groups | 0.387159 |
| better health | 0.563447 |
| United States | 0.432981 |
| tool kit | 0.795546 |
|
| tribal community | 0.376033 |
| cancer prevention efforts | 0.648884 |
| best way | 0.402926 |
| people | 0.252624 |
| community outreach strategy—a | 0.61021 |
| social network profile | 0.599109 |
| complex disease | 0.429302 |
| Web site | 0.372653 |
|
CLICK HERE |
| 11352 |
Centers for Disease Control and Prevention |
Html |
en |
Recommendations for Chemical Protective Clothing: Database |
null |
| dry chemical | 0.463092 |
| direct skin contact | 0.554055 |
| Krister Forsberg | 0.464914 |
| CPC recommendations | 0.491725 |
| contact dermatitis | 0.477274 |
| direct skin hazard | 0.526037 |
| standard temperature conditions | 0.500217 |
| competent industrial hygienist | 0.497885 |
| recommendations | 0.493616 |
| general recommendations | 0.47469 |
| Occupational Safety | 0.461872 |
| standard test method | 0.509114 |
| NIOSH policy | 0.475139 |
| direct contact | 0.510102 |
| systemic toxic effects | 0.515574 |
| breakthrough time | 0.528538 |
| chemical protective clothing | 0.725398 |
| contamination problem | 0.47079 |
| wet skin | 0.469202 |
| skin protection | 0.518482 |
| chemicals | 0.508819 |
| National Institute | 0.465958 |
| Pocket Guide | 0.665423 |
|
| Chemical Abstract Service | 0.506558 |
| chemical manufactures | 0.469093 |
| Protective Clothing database | 0.568771 |
| protective clothing supplier | 0.542832 |
| protective clothing | 0.916805 |
| inadvertent contamination | 0.468503 |
| Quick Selection Guide | 0.515581 |
| significant dermal hazard | 0.517101 |
| unprotected skin | 0.597445 |
| NIOSH Pocket Guide | 0.529011 |
| dermal hazard | 0.585795 |
| Protective Clothing Materials | 0.552873 |
| dermal hazard potential | 0.534526 |
| faster breakthrough | 0.480324 |
| permeation resistance | 0.562551 |
| adverse effects | 0.463473 |
| gaseous contact | 0.468741 |
| skin contact | 0.571288 |
| steady state permeation | 0.55673 |
| designation | 0.462388 |
| protective clothing manufacturers | 0.546203 |
| Continuous Contact | 0.466147 |
| protective barrier | 0.491657 |
|
CLICK HERE |
| 11423 |
Centers for Disease Control and Prevention |
Html |
null |
Posters | Campaign Materials | We Can Stop HIV One Conversation | Campaigns | Act Against AIDS |
Promotional posters of One Conversation at a Time, CDC’s first national effort to encourage Hispanic/Latino families, friends, and communities to talk openly about HIV |
|
|
CLICK HERE |
| 11447 |
Centers for Disease Control and Prevention |
Html |
en |
CDC's Funding |
CDC’s Funding |
| special emphasis | 0.479504 |
| germs | 0.209 |
| health threats | 0.966093 |
| ANTIBIOTIC RESISTANCE | 0.553468 |
| INFECTIOUS OUTBREAKS | 0.599189 |
| simple infections | 0.493446 |
| highest rates | 0.487103 |
| PRESCRIPTION PAINKILLER DRUG | 0.858224 |
|
| disease detection technologies | 0.836858 |
| FY | 0.799339 |
| prescription drug abuse | 0.820542 |
| new health threats | 0.898105 |
| response | 0.252458 |
| ADVANCED MOLECULAR DETECTION | 0.916094 |
| OVERDOSE EPIDEMIC | 0.566379 |
| alarmingly growing epidemic | 0.924676 |
|
CLICK HERE |
| 11464 |
Centers for Disease Control and Prevention |
Html |
en |
Immunization & Respiratory Diseases |
CDC protects all Americans from disease, disability, and death through immunization and by controlling respiratory and other preventable diseases. |
| North Carolina | 0.562545 |
| CDC | 0.639298 |
| 23-case outbreak | 0.596755 |
| Helped partners | 0.595564 |
| effective outbreak field | 0.711628 |
| epidemiology expertise | 0.575055 |
| international partners | 0.55534 |
| local communities | 0.575058 |
| active influenza season | 0.768758 |
| children | 0.455616 |
| measles outbreaks | 0.61003 |
| new H7N9 virus | 0.717492 |
| global health threats | 0.764766 |
| public health decisions | 0.716102 |
| bird flu viruses | 0.691157 |
| severe cases | 0.567389 |
| novel influenza control | 0.77536 |
| potential vaccine virus | 0.725953 |
| virus spreads | 0.572151 |
| urgent health threats | 0.752179 |
| health threats | 0.908743 |
| viral disease threats | 0.763239 |
| avian influenza viruses | 0.742073 |
| birds | 0.44661 |
| H7N9 vaccine | 0.593644 |
|
| H7N9 influenza | 0.640908 |
| states | 0.456752 |
| MERS CoV | 0.601661 |
| public health threats | 0.772421 |
| close contact | 0.554546 |
| studies | 0.445795 |
| H7N9 diagnostic tests | 0.703381 |
| 2M | 0.441721 |
| public health | 0.891336 |
| Middle East Respiratory | 0.72217 |
| CDC scientists | 0.63194 |
| electronic health records | 0.723357 |
| genetic sequences | 0.55456 |
| people | 0.510642 |
| immunization information technologies | 0.722226 |
| whooping cough | 0.587908 |
| human infections | 0.682652 |
| new virus | 0.575221 |
| Vaccine-Preventable Diseases Centers | 0.712695 |
| H7N9 strains | 0.579128 |
| late 1980s | 0.556762 |
| international leadership | 0.575383 |
| localized outbreaks | 0.575338 |
| China’s response | 0.573469 |
|
CLICK HERE |
| 11907 |
Centers for Disease Control and Prevention |
Html |
en |
Update: New York City and CDC Report Positive Tests for Ebola in Volunteer International Aid Worker - 10-24-2014 |
CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos. |
| CDC | 0.399972 |
| multiple layers | 0.402708 |
| confirmation test results | 0.49151 |
| Bellevue Hospital | 0.401149 |
| close communications | 0.395984 |
| Oct. | 0.316389 |
| New York City | 0.918 |
| Health Department laboratory | 0.513578 |
| Disease Control | 0.410358 |
| direct contact | 0.39056 |
| members | 0.326121 |
| healthcare worker | 0.407364 |
| City Health Department | 0.813386 |
| Ebola Response Team | 0.589984 |
| HAZ TAC unit | 0.483452 |
| test results | 0.499947 |
| isolation | 0.317369 |
| countries | 0.316317 |
| travelers | 0.316228 |
| strong suspicion | 0.395452 |
| symptoms | 0.330741 |
| low-grade fever | 0.419385 |
| enhanced screening | 0.401079 |
| West African nations | 0.505605 |
| Ebola epidemic | 0.555579 |
|
| Centers | 0.317837 |
| needles | 0.315879 |
| medical aid worker | 0.512591 |
| night. Additional team | 0.472736 |
| PPE | 0.325954 |
| United States | 0.496052 |
| Guinea | 0.317218 |
| Prevention | 0.317809 |
| Ebola case | 0.507687 |
| technical assistance | 0.394646 |
| incubation period | 0.393261 |
| patient | 0.383699 |
| Personal Protective Equipment | 0.476831 |
| Ebola pending lab | 0.585157 |
| Laboratory Response Network | 0.503793 |
| illness | 0.333607 |
| York City Health | 0.802787 |
| JFK Airport | 0.404986 |
| bodily fluids | 0.396732 |
| Atlanta laboratory | 0.410381 |
| local health officials | 0.489984 |
| sick person | 0.387575 |
| visit http://www.cdc.gov/vhf/ebola | 0.38881 |
| close contacts | 0.396911 |
|
CLICK HERE |
| 15989 |
Centers for Disease Control and Prevention |
Html |
en |
Thank You, CDC Influenza Molecular Diagnostic Performance Evaluation Exercise Enrollment |
This website is intended to facilitate technical support for domestic U.S. and international public health and research institutions performing influenza laboratory surveillance and/or research. |
| Influenza Diagnostic Testing | 0.368017 |
| Flu Illness | 0.465741 |
| Flu Viruses | 0.578597 |
| Flu Vaccines | 0.718731 |
| U.S. Influenza Surveillance | 0.359587 |
| Vaccine Benefits | 0.27901 |
| Prevent Flu | 0.528704 |
| Influenza Testing Results | 0.406465 |
| Flu Good Health | 0.518459 |
| Influenza Viruses | 0.409303 |
| Seasonal Influenza Vaccine | 0.650023 |
| Quadrivalent Influenza Vaccine | 0.557727 |
| Intradermal Influenza | 0.318457 |
| Flu Adults | 0.479376 |
| Flu Activity | 0.465305 |
| Influenza Pandemic Virus | 0.374647 |
| Flu Vaccine | 0.897973 |
| (Flu) | 0.791257 |
| ) Vaccination | 0.578942 |
| Influenza Vaccines | 0.452865 |
| United States Flu | 0.499946 |
| Vaccine Safety Vaccine | 0.502287 |
| Antiviral Drugs Antiviral | 0.291442 |
| Influenza Viruses Types | 0.401434 |
| Flublok Seasonal Influenza | 0.382795 |
|
| Vaccination Flu Vaccination | 0.56543 |
| High-Dose Seasonal Influenza | 0.385031 |
| Control Influenza Transmission | 0.339302 |
| Flu Antiviral Drugs | 0.723605 |
| CDC International Flu | 0.511398 |
| CDC Influenza Molecular | 0.488287 |
| Distribution Vaccine Supply | 0.301129 |
| Prevent Flu Preventive | 0.505969 |
| Flu Vaccine Recommendation | 0.657322 |
| Flu Treatment | 0.485735 |
| Influenza Vaccination Clinic | 0.38851 |
| Flu News | 0.415385 |
| Flu Complications | 0.446476 |
| Flu Season Flu | 0.971451 |
| Diagnosis Flu Symptoms | 0.509214 |
| Flu Vaccine Safety | 0.747052 |
| Cell-Based Flu Vaccines | 0.566465 |
| Flu Season Current | 0.534751 |
| Vaccine Virus Selection | 0.299231 |
| Vaccine Effectiveness | 0.325266 |
| Flu Vaccines Work | 0.579262 |
| Influenza Vaccine Doses | 0.551841 |
| Past Flu Seasons | 0.509974 |
| Influenza 2015-2016 Season | 0.398568 |
|
CLICK HERE |